CLARANOVA – Claranova reverse stock split
Paris, France – June 20, 2019. The Claranova group is pleased to announce the implementation terms of the reverse
See moreCLARANOVA – 9-month revenue of close to €200 million (+59%), revenue growth accelerates in Q3 2018-2019 (+69% to €56.2 million)
Paris, France – May 14, 2019. The Claranova group closes another quarter of high growth, with consolidated revenue up
See more
CLARANOVA – Q1 2018-2019 revenue: growth acceleration confirmed: +61% to €48,2 million.
Paris, France – November 7, 2018. The Claranova group announced today consolidated Q1 revenue (July 1 to September 30,
See moreSPINEWAY – Subscription of first tranche of 100 OCEANE with attached warrants for a par value of 1 M of euros.
Spineway (the “Company”) announces the exercise, on 1st november 2018, by the European High Growth Opportunities Securitization Fund of
See moreSPINEWAY – 2018 half-year results. Revenue for first nine months at €4.8M. Moving forward in the US.
Results reflect the drop in activity. Spineway confirms its strategic repositioning with revenue for the first half of the
See moreSPINEWAY – Marketing of new Mont-Blanc Evo product line authorized in the United States.
This development of the flagship Mont-Blanc line that is already distributed on territory provides surgeons with an implant that
See more
CLARANOVA – Will be present at the Berenberg Pan-European Discovery Conference USA 2018.
Paris, France – October 16, 2018. The Claranova group announces its presence at the American edition of the Berenberg
See more
CLARANOVA – Return to operating profitability confirmed in FY 2017-2018
Paris, France – October 2, 2018. Claranova reports significant across-the-board improvements in results for FY 2017- 2018, confirming its
See moreSPINEWAY – Presents its new Mont-Blanc Evo line at the Eurospine 2018 conference.
Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), gave a preview of
See more
